温州宏豐(300283.SZ)及子公司自4月10日至今累計收到政府補助1116.31萬元
格隆匯12月20日丨温州宏豐(300283.SZ)公佈,自2019年4月10日至公告披露日,公司及下屬子公司温州宏豐特種材料有限公司(“宏豐特材”)、温州宏豐金屬基功能複合材料有限公司(“宏豐金屬基”)、温州宏豐智能科技有限公司(“宏豐智能”)、温州宏豐合金有限公司(“宏豐合金”)、温州蒂麥特動力機械有限公司(“蒂麥特”)累計收到各類政府補助資金共計人民幣1116.31萬元。其中,與收益相關的政府補助資金共計人民幣316.31萬元,與資產相關的政府補助資金共計人民幣800萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.